University of Washington spinout AltPep will use the money to advance work on its lead asset that targets Alzheimer’s disease.
AltPep, a US-based misfolded protein treatment and diagnostics spinout of University of Washington (UW), has closed a $23.1m series A round led by Matrix Capital Management.
Alexandria Venture Investments, the strategic investment division of life sciences real estate investment trust Alexandria Real Estate Equities, also backed the round.
Founded in 2018, AltPep is working on drug treatments and diagnostic tools for central nervous system diseases triggered by misfolded amyloid proteins.
Valorie Daggett, a professor in UW’s Department…
